DataDrivenInvestor December 6, 2023
Flavio Aliberti

Explore Big Pharma’s M&A trends, their impact on supply chains, and the urgent need for adaptability in a rapidly evolving healthcare landscape However, researching partnerships, acquisitions, and divestments made by large multinational firms over time reveals trends and evolutionary patterns in the ecosystem. In this article, I will consider some mergers and acquisitions...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Supply Chain, Technology, Trends
What’s new with GLP-1s
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model

Share Article